Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer

Fig. 1

Expression of CD44s in ampullary cancer. Representative immunohistochemistry analysis of membranous CD44s staining (×400) showing (a) negative immunoreactivity, (b) weak expression of CD44s in < 25 % of ampullary cancer cells, (c) moderate expression of CD44s in 25 to 50 % of ampullary cancer cells, and (d) dense expression of CD44s in > 50 % of ampullary cancer cells

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us